If you are like many pharmaceutical and functional food executives I speak with…
…then expanding distribution of your products across the globe is a highly desirable goal. Yet it is also an onerous task – time-consuming, complex, and fraught with pitfalls.
At CETALUS, an international consulting firm, our focus is helping companies such as yours, with winning human and animal health products market them and secure licensees and distributors amongst 2,000 leading companies in 50 countries where they are not currently sold. Companies that are decisive with new product additions.
We help you secure agreements and shepherd the process to successful commercialization with world-class project management.
In 2017, our efforts on behalf of one client unseated the #1 brand in the Anti-Alzheimer segment. Our prior experiences include attaining a #1 ranking for a functional food. And increasing an animal health business by 5X.
The Head of Business Development for a leading international pharmaceutical company wrote, “Cetalus played a pivotal role in the success of our project. I doubt the deal would have been signed without your assistance.”
Our triple-pronged approach for product licensing combines global strategic thinking and hands-on business development with world-class project management – a proven formula for opening new markets for pharmaceutical and functional food products with potential.
If you have such a winning product, please call me at +1 786-899-5100 x101 or email me at ajay.srinivas@cetalus.com – for a no-cost, no-obligation conference call to explore your product’s potential for licensing and expanding into new markets – and by doing so, dramatically improving your market share, sales, and profitability.
Sincerely,
Ajay Srinivas, President and CEO
Cetalus LLC
Ajay Srinivas
President and CEO, Cetalus LLC
We accept assignments where we believe we can provide superior, practical and transformational benefits for the Principal – Licensor, Discover. Manufacturer and their Clients - Licensee, Marketer, Distributor on a sustainable basis, for example, securing a leading position in a key therapeutic group such as Diabetes or Immune Modulation.
Read More